Greenlane Holdings, Inc. Announces Closing of $25.0 Million Private Placement

BOCA RATON, FL / ACCESS Newswire / February 19, 2025 / Greenlane Holdings, Inc. (NASDAQ:GNLN) (the "Company"), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced the closing of its previously announced private placement of approximately $25.0 million of shares of Common Stock and investor warrants […]

AI and Blockchain Energy Demand Spurs Interest in Nuclear Power and Uranium Investments

The Growing Energy Appetite of AI and Crypto The rapid expansion of %ArtificialIntelligence (AI) and %Cryptocurrency mining has sparked concerns about rising energy consumption. AI data centers and %Blockchain networks require vast amounts of electricity, driving demand for stable and sustainable energy sources. As the world seeks cleaner alternatives, nuclear power has emerged as a

Glasshouse Realty Group launches luxury brand for residential real estate

Glasshouse Luxury plans to become the go-to leader for luxury listings in the tristate area Glasshouse Realty Group – a full-service real estate brokerage with 10 offices throughout Ohio – formally launched Glasshouse Luxury, a business line dedicated to servicing high-end residential real estate transactions. The launch of Glasshouse Luxury, which coincides with the closing

Suzanne Klopfenstein to Retire After 32 Years at Cox First Media

Rob Rohr Returns to Dayton to Lead the Next Chapter of Growth and Innovation of our Trusted News Brands Cox First Media announces the retirement of Suzanne Klopfenstein, who will be stepping down as Publisher on June 30, 2025. Over her 32-year career with Cox, Suzanne has been instrumental in leading change, driving innovation, and

Advisors Excel Raises $1.7 Million for Four National Nonprofits at Annual Event

Advisors Excel, a leading marketing organization supporting independent financial professionals, announced a remarkable fundraising achievement of $1.7 million in support of four impactful organizations-Folds of Honor, The V Foundation for Cancer Research, Camp Southern Ground, and The Jones Project. The funds were raised during Advisors Excel's annual World Series of Success event in partnership with

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PLYA, GB, TGI, AVAV on Behalf of Shareholders

(NASDAQ:PLYA),(NYSE:GB),(NYSE:TGI),(NASDAQ:AVAV), NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Playa Hotels & Resorts N.V. (NASDAQ: PLYA)'s sale to Hyatt Hotels Corporation for $13.50 per share.

VISION 2025: A Resounding Success in Advancing Venous and Lymphatic Medicine

VISION 2025 successfully brought together thought leaders, healthcare professionals, and innovators in venous and lymphatic medicine for a transformative learning experience. Hosted by Center for Vein Restoration (CVR) at the Baltimore Marriott Waterfront, this premier conference provided cutting-edge clinical and non-clinical programming that achieved its goals of enhancing medical expertise, fostering collaboration, and strengthening professional

Analysis: A Focus on Retaining Talent Will Save Time and Money on Recruiting Talent

Employee turnover is costly for companies, posing significant business risks. A new analysis by The Conference Board highlights the strong business case for investing in talent retention-not just to mitigate turnover costs but to enhance competitiveness as well. https://mma.prnewswire.com/media/624268/The_Conference_Board_Logo.jpg “Making employee retention a staple of your talent strategy can provide a competitive edge-preserving institutional knowledge,

SUPN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Supernus Pharmaceuticals, Inc.

NEW YORK, NY / ACCESS Newswire / February 19, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus Pharmaceuticals, Inc. ("Supernus Pharmaceuticals, Inc.") (NASDAQ:SUPN) concerning possible violations of federal securities laws. On February 19, 2025, The company announced that its Phase 2b study of SPN-820 for treatment-resistant depression failed

Scroll to Top